Several epidemiological studies have demonstrated that elevated circulating PAI-1 levels and PAI-1 activity are an important feature of or even a marker for the development of metabolic disturbances including obesity, type 2 diabetes, and metabolic syndrome [59,60,61]. The gene discussed is SERPINE1; the disease is obesity disorder.